Publications by authors named "M Trapecar"

The regular workshops held by the Center for Alternatives to Animal Testing (CAAT) on biology-inspired microphysiological systems (MPS) taking place every four years, have become a reliable measure to assess fundamental scientific, industrial and regulatory trends for translational science in the MPS-field from a bird's eye view. The 2023 workshop participants at that time concluded that the technology as used within academia has matured significantly, underlined by the broad use of MPS and the steadily increasing number of high quality research publications - yet, broad industry adoption of MPS has been slow, despite strong interest. Academic research using MPS primarily aims to accurately recapitulate human biology in MPS-based organ models in areas where traditional models have been lacking key elements of human physiology, thereby enabling breakthrough discoveries for life sciences.

View Article and Find Full Text PDF
Article Synopsis
  • - Gamma delta T (γδ T) cells are important for fighting tumors, but their role in producing the pro-tumor IL-17 in colorectal cancer (CRC) is debated.
  • - Analyzed data from 165 human CRC patients showed that while γδ T cells are highly cytotoxic, they do not produce IL-17 in tumor environments.
  • - The study identifies different γδ T cell subsets and suggests that effective anti-tumor γδ T cells may develop from tissue-resident cells, emphasizing the need for careful characterization of these cells for cancer treatments and considering differences between human and mouse immune responses.
View Article and Find Full Text PDF

Gamma delta (γδ) T cells play a crucial role in anti-tumor immunity due to their cytotoxic properties. However, the role and extent of γδ T cells in production of pro-tumorigenic interleukin- 17 (IL-17) within the tumor microenvironment (TME) of colorectal cancer (CRC) remains controversial. In this study, we re-analyzed nine published human CRC whole-tissue single-cell RNA sequencing (scRNA-seq) datasets, identifying 18,483 γδ T cells out of 951,785 total cells, in the neoplastic or adjacent normal tissue of 165 human CRC patients.

View Article and Find Full Text PDF